This is not the most recent version of the article. View current version (4 APR 2016)

Intervention Review

Dornase alfa for cystic fibrosis

  1. Ashley P Jones1,*,
  2. Colin Wallis2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 29 NOV 2009

DOI: 10.1002/14651858.CD001127.pub2


How to Cite

Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD001127. DOI: 10.1002/14651858.CD001127.pub2.

Author Information

  1. 1

    University of Liverpool, Institute of Child Health, Liverpool, Merseyside, UK

  2. 2

    Great Ormond Street Hospital for Children NHS Trust, Respiratory Unit, London, UK

*Ashley P Jones, Institute of Child Health, University of Liverpool, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, Merseyside, L12 2AP, UK. apjones@liverpool.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 17 MAR 2010

SEARCH

This is not the most recent version of the article. View current version (04 APR 2016)

  1. Current Version

    Dornase alfa for cystic fibrosis

    Connie Yang, Mark Chilvers, Mark Montgomery and Sarah J Nolan

    Version of Record online: 4 APR 2016 | DOI: 10.1002/14651858.CD001127.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Dornase alfa for cystic fibrosis

    Ashley P Jones and Colin Wallis

    Version of Record online: 17 MAR 2010 | DOI: 10.1002/14651858.CD001127.pub2

  2. Version 1

    Dornase alfa for cystic fibrosis

    Ashley P Jones, Colin Wallis and Catherine E Kearney

    Version of Record online: 21 JUL 2003 | DOI: 10.1002/14651858.CD001127